ITEM 1. FINANCIAL STATEMENTS
CLIMATEROCK
BALANCE SHEET
| |
June 30, 2022 | | |
December 31, 2021 | |
ASSETS | |
(Unaudited) | | |
| |
Current assets: | |
| | |
| |
Cash | |
$ | 299,401 | | |
$ | — | |
Prepaid expenses | |
| 276,278 | | |
| — | |
Deferred offering costs | |
| — | | |
| 83,343 | |
Investment held in trust account | |
| 80,017,979 | | |
| — | |
Total current assets | |
| 80,593,658 | | |
| 83,343 | |
TOTAL ASSETS | |
$ | 80,593,658 | | |
$ | 83,343 | |
| |
| | | |
| | |
LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accrued liabilities | |
$ | 32,289 | | |
$ | — | |
Loan payable - related party | |
| — | | |
| 63,073 | |
Deferred underwriting commission payable | |
| 2,362,500 | | |
| — | |
Total current liabilities | |
| 2,394,789 | | |
| 63,073 | |
TOTAL LIABILITIES | |
$ | 2,394,789 | | |
$ | 63,073 | |
| |
| | | |
| | |
COMMITMENTS AND CONTINGENCIES | |
| | | |
| | |
Class A common stock, $0.0001 par value, subject to possible redemption. 7,875,000 shares at redemption value of $10.16 per share, including dividends earned in trust account | |
$ | 80,017,979 | | |
$ | — | |
| |
| | | |
| | |
SHAREHOLDERS’ (DEFICIT) EQUITY | |
| | | |
| | |
Class A ordinary shares, $0.0001 par value; 479,000,000 shares authorized; 118,125 issued and outstanding (excluding 7,875,000 shares subject to possible redemption as of June 30, 2022) | |
$ | 12 | | |
$ | — | |
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 1,968,750 and 2,156,250 issued and outstanding as of June 30, 2022 and December 31, 2021, respectively (1) | |
| 197 | | |
| 216 | |
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | |
| — | | |
| — | |
Additional paid-in capital | |
| — | | |
| 24,784 | |
Accumulated deficit | |
| (1,819,319 | ) | |
| (4,730 | ) |
Total shareholders’ (deficit) equity | |
$ | (1,819,110 | ) | |
$ | 20,270 | |
TOTAL LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY | |
$ | 80,593,658 | | |
$ | 83,343 | |
| (1) | The number of ordinary shares issued and outstanding at December
31, 2021 includes an aggregate of up to 281,250 shares of non-redeemable founder shares that are subject to forfeiture if the underwriter
does not exercise the over-allotment option. In connection with the closing of the initial public offering and the underwriter’s
partial exercise of over-allotment option on May 2, 2022, 93,750 of the founder shares were no longer subject to forfeiture, and 187,500
of the founder shares were forfeited. |
The accompanying notes
are an integral part of these financial statements
CLIMATEROCK
STATEMENT OF OPERATIONS (UNAUDITED)
| |
Three Months Ended June 30, 2022 | | |
Six Months Ended June 30, 2022 | |
Operating expenses | |
| | |
| |
Formation and operating costs | |
$ | 271,669 | | |
$ | 272,869 | |
Net Loss from operations | |
| (271,669 | ) | |
| (272,869 | ) |
| |
| | | |
| | |
Other income | |
| | | |
| | |
Investment income on trust account | |
| 86,729 | | |
| 86,729 | |
Total other income | |
| 86,729 | | |
| 86,729 | |
Net loss | |
$ | (184,940 | ) | |
$ | (186,140 | ) |
| |
| | | |
| | |
Basic and diluted weighted average shares outstanding | |
| | | |
| | |
Redeemable ordinary shares, basic and diluted | |
| 5,192,308 | | |
| 2,610,497 | |
Non-redeemable ordinary shares, basic and diluted | |
| 2,014,698 | | |
| 1,945,235 | |
| |
| | | |
| | |
Redeemable ordinary shares, basic and diluted net income per share | |
$ | 0.66 | | |
$ | 2.05 | |
Non-redeemable ordinary shares, basic and diluted net loss per share | |
$ | (1.80 | ) | |
$ | (2.85 | ) |
The accompanying notes
are an integral part of these financial statements
CLIMATEROCK
STATEMENT OF CHANGES IN SHAREHOLDER’S EQUITY (UNAUDITED)
FOR THE SIX MONTHS ENDED JUNE 30, 2022
| |
CLASS
A ORDINARY SHARES | | |
CLASS
B ORDINARY SHARES | | |
PREFERENCE
SHARES | | |
ADDITIONAL PAID-IN | | |
ACCUMULATED | | |
TOTAL SHAREHOLDERS’
(DEFICIT) | |
| |
SHARES | | |
AMOUNT | | |
SHARES | | |
AMOUNT | | |
SHARES | | |
AMOUNT | | |
CAPITAL | | |
DEFICIT | | |
EQUITY | |
Balances - December
31, 2021 | |
| — | | |
$ | — | | |
| 2,156,250 | | |
$ | 216 | | |
| — | | |
$ | — | | |
$ | 24,784 | | |
$ | (4,730 | ) | |
$ | 20,270 | |
Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (1,200 | ) | |
| (1,200 | ) |
Balances
- March 31, 2022 (1) | |
| — | | |
$ | — | | |
| 2,156,250 | | |
$ | 216 | | |
| — | | |
$ | — | | |
$ | 24,784 | | |
$ | (5,930 | ) | |
$ | 19,070 | |
Forfeiture of 187,500 Class B ordinary shares by initial shareholder | |
| — | | |
| — | | |
| (187,500 | ) | |
| (19 | ) | |
| — | | |
| — | | |
| 19 | | |
| — | | |
| — | |
Sale of 7,875,000 units at $10 per unit in IPO,including over-allotment, net of underwriters’ discount and offering expenses | |
| 7,875,000 | | |
| 788 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 73,655,270 | | |
| — | | |
| 73,656,058 | |
Issuance of 118,125 underwriter units, including over-allotment | |
| 118,125 | | |
| 12 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 946,169 | | |
| — | | |
| 946,181 | |
Sale of 3,762,500 warrants in private placement | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 3,762,500 | | |
| — | | |
| 3,762,500 | |
Adjustment to increase Class
A ordinary shares subject to possible redemption to maximum redemption value | |
| (7,875,000 | ) | |
| (788 | ) | |
| — | | |
| — | | |
| — | | |
| — | | |
| (78,388,742 | ) | |
| (1,628,449 | ) | |
| (80,017,979 | ) |
Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (184,940 | ) | |
| (184,940 | ) |
Balances
- June 30, 2022 | |
| 118,125 | | |
$ | 12 | | |
| 1,968,750 | | |
$ | 197 | | |
| — | | |
$ | — | | |
$ | — | | |
$ | (1,819,319 | ) | |
$ | (1,819,110 | ) |
| (1) | The number of ordinary shares issued and outstanding at December 31, 2021 includes an aggregate of up
to 281,250 shares of non-redeemable founder shares that are subject to forfeiture if the underwriter does not exercise the over-allotment
option. In connection with the closing of the initial public offering and the underwriter’s partial exercise of over-allotment option
on May 2, 2022, 93,750 of the founder shares were no longer subject to forfeiture, and 187,500 of the founder shares were forfeited. |
The accompanying notes
are an integral part of these financial statements
CLIMATEROCK
STATEMENT OF CASH FLOWS (UNAUDITED)
FOR THE SIX MONTHS ENDED JUNE 30, 2022
Cash flows from operating activities: | |
| |
Net loss | |
$ | (186,140 | ) |
Adjustment to reconcile net loss to net cash used in operating
activities: | |
| | |
Investment income received in Trust Account | |
| (86,729 | ) |
Change in operating assets and liabilities: | |
| | |
Accrued liabilities | |
| 32,289 | |
Prepaid expenses | |
| (276,278 | ) |
Net cash used in operating activities | |
$ | (516,858 | ) |
| |
| | |
Cash flows from investing activities: | |
| | |
Cash deposited in Trust Account | |
| (79,931,250 | ) |
Net cash used in investing activities | |
$ | (79,931,250 | ) |
| |
| | |
Cash flows from financing activities: | |
| | |
Proceed from related party loan | |
| 5,150 | |
Repayment of related party loans | |
| (217,641 | ) |
Proceeds from sale of units in IPO, including over-allotment | |
| 78,750,000 | |
Payment of underwriting fee and other offering costs | |
| (1,552,500 | ) |
Proceeds from sale of warrants in private placement | |
| 3,762,500 | |
Net cash provided by financing activities | |
$ | 80,747,509 | |
| |
| | |
Net increase in cash | |
$ | 299,401 | |
Cash at beginning of period | |
| — | |
Cash at end of period | |
$ | 299,401 | |
| |
| | |
Non-cash investing and financial activities: | |
| | |
Deferred offering costs paid by related party | |
$ | 149,418 | |
Deferred underwriting commission charged to additional paid in capital | |
| 2,362,500 | |
Allocation of offering costs to Class A ordinary shares subject to redemption | |
| 304,011 | |
Issuance of representative shares | |
| 946,181 | |
Initial value of public shares subject to possible redemption | |
| 71,851,500 | |
Reclassification of offering costs related to public shares | |
| (4,647,702 | ) |
Remeasurement adjustment on public shares subject to possible redemption | |
| 12,814,181 | |
The accompanying notes
are an integral part of these financial statements
CLIMATEROCK
NOTES TO THE FINANCIAL STATEMENTS (UNAUDITED)
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS
ClimateRock (the “Company”)
is a Cayman Islands exempted company incorporated as a blank check company on December 6, 2021. The Company was incorporated for the purpose
of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more
businesses that the Company has not yet identified (“Business Combination”). Although the Company is not limited to a particular
industry or geographic region for purposes of consummating a Business Combination, the Company focuses on opportunities in climate change,
environment, renewable energy and emerging, clean technologies.
At June 30, 2022,
the Company had not yet commenced operations. All activity through June 30, 2022 relates to the Company’s formation and
the initial public offering (the “Initial Public Offering”), which is described below, and post-offering activities in search for a target to consummate a Business Combination. The Company has selected
December 31 as its fiscal year end.
The registration statement
for the Company’s Initial Public Offering was declared effective on April 27, 2022.
On May 2, 2022, the Company consummated its Initial Public Offering of 7,875,000 units (“Units” and, with respect to the Class
A ordinary shares included in the Units being offered, the “Public Shares”) at $10.00 per Unit, including 375,000 Units that
were issued pursuant to the underwriters’ partial exercise of their over-allotment option, generating gross proceeds of $78,750,000.
Simultaneously with the closing
of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 3,762,500 warrants
(“Private Placement Warrants”) at a price of $1.00 per warrant to the Company’s sponsor, U.N. SDG Support LLC,
a Delaware limited liability company (“Sponsor”), generating gross proceeds of $3,762,500 (see Note 4).
Offering costs amounted to
$5,093,930, consisting of $1,181,250 of underwriting fees, $2,362,500 of deferred underwriting commissions payable (which are held in
the Trust Account as defined below), $946,169 of representative shares (see Note 6), and $604,011 of other offering costs. As described
in Note 6, the $2,362,500 of deferred underwriting commissions payable is contingent upon the consummation of a Business Combination,
subject to the terms of the underwriting agreement.
Upon the closing of the Initial
Public Offering and Private Placement, $79,931,250 of the net proceeds of the sale of the Units in the Initial Public Offering and the
Private Placement was placed in a trust account (the “Trust Account”) and will be invested in U.S. government securities,
within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, with
a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company
meeting the conditions of paragraphs (c)(2), (c)(3) and (c)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company,
until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
At June 30, 2022, the
Company had $299,401 in cash held outside of the Trust Account. The Company’s management has broad discretion with respect to the
specific application of the net proceeds of its Initial Public Offering and Private Placement Warrants, although substantially all of
the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business
Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held
in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting
discount held in trust) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However,
the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding
voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register
as an investment company under the Investment Company Act 1940, as amended, or the Investment Company Act.
CLIMATEROCK
NOTES TO THE FINANCIAL STATEMENTS (UNAUDITED)
The Company will provide
holders of its Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares
upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination
or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or
conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their
Public Shares for a pro rata portion of the amount then in the Trust Account (initially approximately $10.15 per share, plus any pro rata
interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share
amount to be distributed to public shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions
the Company will pay to the underwriters (as discussed in Note 6).
The Company will have until
12 months from the closing of this offering to consummate an initial Business Combination. However, if the Company anticipates that it
may not be able to consummate the initial Business Combination within 12 months, it may extend the period of time to consummate a Business
Combination by two additional 3-month periods (for a total of up to 18 months) without submitting proposed extensions to its shareholders
for approval or offering its public shareholders redemption rights in connection therewith. The Company’s sponsor or its affiliates
or designees, upon five days advance notice prior to the applicable deadline, must deposit into the trust account $787,500 ($0.10 per
share) on or prior to the date of the applicable deadline for each additional three month period. Any such payments would be made in the
form of a loan, non-interest bearing and payable upon the consummation of the initial Business Combination.
Going concern and management’s plan
As of June 30, 2022, the Company has a cash balance of $299,401 and
a working capital deficit of $543,390, excluding the cash currently held in the Trust Account and the deferred compensation payable upon
consummation of a Business Combination. The Company has incurred and expects to continue to incur significant costs in pursuit of its
financing and acquisition plans. These conditions raise substantial doubt about the Company’s ability to continue as a going concern
one year from the issuance date of the financial statements. Prior to consummation of a Business Combination, the Company has the ability
to secure additional funding from the Sponsor or other related parties. There is no assurance that the Company’s plans to consummate
a Business Combination will be successful within 12 months (or 18 months, as applicable) (the “Combination Period”). The financial
statements do not include any adjustments that might result from the outcome of this uncertainty.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Basis of presentation
The accompanying financial
statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”)
and pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”).
The accompanying unaudited
financial statements as of June 30, 2022, and for the period from January 1, 2022 through June 30, 2022 have been prepared in
accordance with U.S. GAAP for interim financial information and Article 10 of Regulation S-X. In the opinion of management, all adjustments
(consisting of normal accruals) considered for a fair presentation have been included. Operating results for the period from January 1,
2022 through June 30, 2022 are not necessarily indicative of the results that may be expected for the period ending December 31,
2022, or any future period.
CLIMATEROCK
NOTES TO THE FINANCIAL STATEMENTS (UNAUDITED)
The accompanying unaudited
condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K
and the final prospectus filed by the Company with the SEC on May 6, 2022 and April 29, 2022, respectively.
Cash and cash equivalents
The Company considers all
short-term investments with a maturity of three months or less when purchased to be cash equivalents. As of June 30, 2022 and December
31, 2021, the Company had a cash balance of $299,401 and $0 in its working capital account, respectively, and no cash equivalents.
Investment in Trust Account
Upon the closing of the IPO
and private placement, $79,931,250 was placed into a trust account (the “Trust Account”) with J.P. Morgan Asset Management.
The funds held in the trust
account can be invested in United States government treasury bills, notes or bonds having a maturity of 185 days or less or in money market
funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, until the earlier
of the consummation of its first business combination and the Company’s failure to consummate a business combination within 12 months
(or 18 months as applicable) from the consummation of the IPO.
The Company’s investments
held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at
the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included
in investment income on trust account in the accompanying statements of operations. The estimated fair values of investments held in Trust
Account are determined using available market information. (see Note 8).
At June 30, 2022, the Company
had $80,017,979 held in the Trust Account, including $86,729 dividends earned on investments held in Trust Account.
Emerging growth company
The Company is an “emerging
growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified
by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from
various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not
limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding
a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, section 102(b)(1)
of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period
which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,
as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company
nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential
differences in accountant standards used.
CLIMATEROCK
NOTES TO THE FINANCIAL STATEMENTS (UNAUDITED)
Use of estimates
The preparation of financial
statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues
and expenses during the reporting period. Accordingly, the actual results could differ significantly from those estimates.
Deferred offering costs
The Company complies with
the requirements of the Financial Accounting Standard Board (the “FASB”) Accounting Standards Codification (“ASC”)
340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offerings.” Offering costs, consist of legal,
accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public
Offering, were charged to shareholders’ equity upon the completion of the Initial Public Offering. As of December 31, 2021, deferred
offering costs amounted to $83,343 and consisted of legal, accounting, and underwriting fees. Upon consummation of the IPO on May 2, 2022,
total offering costs related to the IPO were $5,093,930, and was allocated between the Public Shares, public warrants and public rights
based on their relative fair values at the date of issuance. Accordingly, $4,647,702 was allocated to the Public Shares and charged to
temporary equity (see Note 3).
Ordinary shares subject to possible redemption
The Company accounts for
its Class A ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing
Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and
are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are
either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s
control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s
public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence
of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value (plus any interest
earned and/or dividends on the Trust Account) as temporary equity, outside of the shareholders’ equity section of the Company’s
balance sheets.
Income taxes
The Company complies with
the accounting and reporting requirements of Accounting Standards Codification (“ASC”) Topic 740, “Income Taxes,”
which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and
liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future
taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to
affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be
realized.
ASC Topic 740 prescribes
a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or
expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained
upon examination by taxing authorities.
The Company’s management
determined that the Cayman Islands is the Company’s only major tax jurisdiction. There is currently no taxation imposed on income
by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company.
Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect
that the total amount of unrecognized tax benefits will materially change over the next twelve months.
CLIMATEROCK
NOTES TO THE FINANCIAL STATEMENTS (UNAUDITED)
Net loss per share
The Company complies with
accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” In order to determine the net income (loss)
attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable
to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less
interest income in trust account less any dividends paid. We then allocated the undistributed income (loss) ratably based on the weighted
average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption
value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders. At June 30,
2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary
shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the
periods presented.
The net income (loss) per
share presented in the condensed statement of operations is based on the following:
|
|
Three months ended
June 30,
2022 |
|
|
Six months ended
June 30,
2022 |
|
Net loss |
|
$ |
(184,940 |
) |
|
$ |
(186,140 |
) |
Accretion of temporary equity to redemption value |
|
|
(12,727,452 |
) |
|
|
(12,727,452 |
) |
Net loss including accretion of temporary equity to redemption value |
|
$ |
(12,912,392 |
) |
|
$ |
(12,913,592 |
) |
Less: Investment income on trust account to be allocated to redeemable shares |
|
|
86,729 |
|
|
|
86,729 |
|
Net loss excluding investment income on trust account |
|
$ |
(12,999,121 |
) |
|
$ |
(13,000,321 |
) |
|
|
Three months ended
June 30, 2022 |
|
|
|
Redeemable shares |
|
|
Non-redeemable shares |
|
Basic and diluted net income/(loss) per share: |
|
|
|
|
|
|
Numerators: |
|
|
|
|
|
|
Allocation of net loss including accretion of temporary equity and excluding investment income on trust account |
|
$ |
(9,365,254 |
) |
|
$ |
(3,633,867 |
) |
Investment income on trust account |
|
|
86,729 |
|
|
|
|
|
Accretion of temporary equity to redemption value |
|
|
12,727,452 |
|
|
|
|
|
Allocation of net income/(loss) |
|
$ |
3,448,927 |
|
|
$ |
(3,633,867 |
) |
|
|
|
|
|
|
|
|
|
Denominators: |
|
|
|
|
|
|
|
|
Weighted-average shares outstanding |
|
|
5,192,308 |
|
|
|
2,014,698 |
|
Basic and diluted net income/(loss) per share |
|
$ |
0.66 |
|
|
$ |
(1.80 |
) |
|
|
Six months ended
June 30, 2022 |
|
|
|
Redeemable shares |
|
|
Non-redeemable shares |
|
Basic and diluted net income/(loss) per share: |
|
|
|
|
|
|
Numerators: |
|
|
|
|
|
|
Allocation of net loss including accretion of temporary equity and excluding investment income on trust account |
|
$ |
(7,449,362 |
) |
|
$ |
(5,550,959 |
) |
Investment income on trust account |
|
|
86,729 |
|
|
|
|
|
Accretion of temporary equity to redemption value |
|
|
12,727,452 |
|
|
|
|
|
Allocation of net income/(loss) |
|
$ |
5,364,819 |
|
|
$ |
(5,550,959 |
) |
|
|
|
|
|
|
|
|
|
Denominators: |
|
|
|
|
|
|
|
|
Weighted-average shares outstanding |
|
|
2,610,497 |
|
|
|
1,945,235 |
|
Basic and diluted net income/(loss) per share |
|
$ |
2.05 |
|
|
$ |
(2.85 |
) |
CLIMATEROCK
NOTES TO THE FINANCIAL STATEMENTS (UNAUDITED)
Fair value of financial instruments
The fair value of the Company’s
assets and liabilities, which qualify as financial instruments under the FASB ASC 825, “Financial Instruments” approximates
the carrying amounts represented in the balance sheet, primarily due to its short-term nature.
Fair value is defined as
the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants
at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
| ● | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in
active markets; |
| ● | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly
observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets
that are not active; and |
| ● | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring
an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs
or significant value drivers are unobservable. |
In some circumstances, the
inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair
value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the
fair value measurement.
Recent accounting pronouncements
Management does not believe
that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have an effect on the Company’s
financial statements.
Risks and uncertainties
Management is currently evaluating
the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect
on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily
determinable as of the date of these financial statements.
NOTE 3. INITIAL PUBLIC OFFERING
On May 2, 2022, the Company
consummated its Initial Public Offering of 7,875,000 Units, including 375,000 Units that were issued pursuant to the underwriters’
partial exercise of their over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company
of $78,750,000.
Each unit consists of one
Class A ordinary share, one-half of one redeemable warrant and one right. Each whole warrant entitles the holder thereof to purchase one
ordinary share for $11.50 per share, subject to certain adjustment. Each right entitles the holder to receive one-tenth of one ordinary
share upon consummation of the Company’s initial Business Combination (see Note 7).
CLIMATEROCK
NOTES TO THE FINANCIAL STATEMENTS (UNAUDITED)
All of the 7,875,000 public
shares sold as part of the Public Units in the Initial Public Offering contain a redemption feature which allows for the redemption of
such public shares if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain
amendments to the Company’s amended and restated certificate of incorporation, or in connection with the Company’s liquidation.
In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99,
redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside
of permanent equity.
As of June 30, 2022, the
ordinary shares reflected on the balance sheet are reconciled in the following table.
| |
As of
June 30,
2022 | |
Gross proceeds | |
$ | 78,750,000 | |
Less: | |
| | |
Proceeds allocated to public warrants and public rights | |
| (6,898,500 | ) |
Offering costs of public shares | |
| (4,647,702 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 12,814,181 | |
Ordinary shares subject to possible redemption | |
$ | 80,017,979 | |
NOTE 4. PRIVATE PLACEMENT
On May 2, 2022, the Company
sold 3,762,500 Private Placement Warrants, including 112,500 Private Placement Warrants that were issued pursuant to the underwriters’
partial exercise of the over-allotment option, at $1.00 per warrant, generating gross proceeds of $3,762,500 in the Private Placement.
Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. A portion of the net proceeds
from the Private Placement was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not
complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder shares
On December 30, 2021, the
Company issued 2,156,250 of its Class B ordinary shares to the Sponsor (the “Founder Shares”) for $25,000 at a par value of
$0.0001, which included an aggregate of up to 281,250 Class B ordinary shares subject to forfeiture if the over-allotment option was not
exercised in full or in part by the underwriters (see Note 6). The Sponsor had paid $25,000 in exchange for the shares through a related
party before December 31, 2021.
Since the underwriters partially
exercised the over-allotment option in respect of 375,000 Units and, as agreed with the Company, the underwriters waived their right to
further exercise the option (see Note 6), a total of 93,750 of the Founder Shares were no longer subject to forfeiture on May 2, 2022,
and 187,500 of the Founder Shares were forfeited, resulting in an aggregate of 1,968,750 Founder Shares issued and outstanding.
CLIMATEROCK
NOTES TO THE FINANCIAL STATEMENTS (UNAUDITED)
Promissory note
The member of the Sponsor
has agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering (the “Note”).
The Note is non-interest bearing, unsecured and was due on the closing of the Initial Public Offering. As of June 30, 2022 and December
31, 2021, the Company has not borrowed any funds under the Note. The Note expired on May 2, 2022 and will not be extended or renewed.
Loan with related party
The Company has agreed to
borrow up to $500,000 from Eternal B.V., an affiliate of the Company through common ownership, to be used for the payment of costs related
to the Initial Public Offering (the “Loan”). Pursuant to the loan agreement and its subsequent amendments, the Note is non-interest
bearing, unsecured and was due on the closing of the Initial Public Offering. As of December 31, 2021, the outstanding balance of loan
payable to the affiliate was $63,073, and no interest was accrued. The Loan expired on May 2, 2022 and was fully repaid to the affiliate
on June 2, 2022.
Administrative service fee
The Company entered
into an administrative services agreement (the “Administrative Services Agreement”) with the Sponsor on April 27, 2022
whereby the Sponsor will perform certain services for the Company for a monthly fee of $10,000. On May 2, 2022, the Sponsor entered
into an assignment agreement with Gluon Group, an affiliate of the Company, to provide the services detailed in the Administrative
Service Agreement. An officer of the Company owns 50% shares of Gluon Group and serves as managing partner. As of June 30, 2022,
$10,000 has been paid to Gluon Group for such services and $10,000 has been accrued, an additional $5,000 was also paid to Gluon
Group as a reimbursement of travel expense.
NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration rights
The holders of the Founder
Shares and warrants are entitled to registration rights pursuant to a registration rights agreement signed on April 27, 2022. The holders
of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities.
In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent
to the consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration
statements.
Underwriting agreement
On October 21, 2021, the
Company engaged Maxim Group LLC (“Maxim”) as its underwriter. The Company granted the underwriters a 45-day option until June
11, 2022 to purchase up to 1,125,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the
underwriting discounts and commissions. On May 2, 2022, the underwriters partially exercised this option in respect of 375,000 Units and,
as agreed with the Company, the underwriters waived their right to further exercise the option on May 5, 2022.
The underwriters were entitled
to an underwriting discount of $0.45 per unit, or $3,543,750 in the aggregate, of which $0.15 per unit, or $1,181,250 was paid
upon the closing of the Initial Public Offering. Of the $0.45 discount, the underwriters were entitled to a deferred underwriting commission
of $0.30 per unit, or $2,362,500 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held
in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
In addition to the underwriting
discount, the Company has agreed to pay or reimburse the underwriters for travel, lodging and other “road show” expenses,
expenses of the underwriters’ legal counsel and certain diligence and other fees, including the preparation, binding and delivery
of bound volumes in form and style reasonably satisfactory to the representative, transaction Lucite cubes or similar commemorative items
in a style as reasonably requested by the representative, and reimbursement for background checks on our directors, director nominees
and executive officers, which such fees and expenses are capped at an aggregate of $125,000 (less amounts previously paid). The $125,000
was paid out of the proceeds of the Initial Public Offering on May 2, 2022.
CLIMATEROCK
NOTES TO THE FINANCIAL STATEMENTS (UNAUDITED)
Representative shares
The Company has issued to
Maxim and/or its designees, 118,125 shares of Class A ordinary shares upon the consummation of the Initial Public Offering (the “Representative
Shares”). The Company accounted for the Representative Shares as an offering cost associated with the Initial Public Offering, with
a corresponding credit to shareholder’s equity. The Company estimated the fair value of Representative Shares to be $946,181. Maxim
has agreed not to transfer, assign, or sell any such shares until the completion of the Business Combination. In addition, Maxim has agreed:
(i) to waive its redemption rights with respect to such shares in connection with the completion of the Business Combination; and (ii)
to waive its rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete its
Business Combination within 12 months (or 18 months, as applicable) from the closing of the Initial Public Offering.
The shares have been deemed
compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the effectiveness
of the registration statement of which this prospectus forms a part pursuant to Rule 5110(e)(1) of FINRA’s NASD Conduct Rules. Pursuant
to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative, put, or call transaction that
would result in the economic disposition of the securities by any person for a period of 180 days immediately following April 27, 2022,
nor may they be sold, transferred, assigned, pledged, or hypothecated for a period of 180 days immediately following April 27, 2022 except
to any underwriter and selected dealer participating in the offering and their bona fide officers or partners.
Subject to certain conditions,
the Company granted Maxim, for a period beginning on May 2, 2022 and ending 12 months after the date of the consummation of the Business
Combination, a right of first refusal to act as book-running managing underwriter or placement agent for any and all future public and
private equity, equity-linked, convertible and debt offerings for the Company or any of its successors or subsidiaries. In accordance
with FINRA Rule 5110(g)(6), such right of first refusal shall not have a duration of more than three years from April 27, 2022.
NOTE 7. SHAREHOLDER’S EQUITY
Class A Ordinary Shares
— The Company is authorized to issue 479,000,000 Class A ordinary shares with a par value of $0.0001
per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of June 30, 2022 and
December 31, 2021, there were 118,125 and zero Class A shares issued and outstanding, respectively.
Class B Ordinary Shares
— The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001
per share. Holders of the Company’s Class B ordinary shares are entitled to one vote for each share. As of June 30, 2022 and
December 31, 2021, there were 1,968,750 and 2,156,250 Class B ordinary shares outstanding, respectively. As of December 31, 2021, the
Class B ordinary shares outstanding included an aggregate of up to 281,250 shares subject to forfeiture if the over-allotment option is
not exercised in full or in part by the underwriters (see Note 6). Since the underwriters partially exercised the over-allotment option
in respect of 375,000 Units and, as agreed with the Company, the underwriters waived their right to further exercise the option (see Note
6), a total of 93,750 of the Founder Shares were no longer subject to forfeiture on May 2, 2022, and 187,500 of the Founder Shares were
forfeited, resulting in an aggregate of 1,968,750 Founder Shares issued and outstanding.
Preference Shares
— The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share. As of June 30,
2022 and December 31, 2021, there were no preferred shares outstanding.
CLIMATEROCK
NOTES TO THE FINANCIAL STATEMENTS (UNAUDITED)
Warrants —
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering (together,
the “Warrants”), except that the Private Placement Warrants will be subject to certain restrictions on transfer and entitled
to registration rights.
The Warrants may only be
exercised for a whole number of shares. The Private Placement Warrants (including ordinary shares issuable upon exercise of the Private
Placement Warrants) will not be transferable, assignable, or salable until 30 days after the completion of our initial business combination.
Following such period, the Private Placement Warrants (including the ordinary shares issuable upon exercise of the Private Placement Warrants)
will be transferable, assignable, or salable, except that the Private Placement Warrants will not trade. No fractional Public Warrants
will be issued upon separation of the Units and only whole Public Warrants will trade.
The Warrants will become
exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial
Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the
ordinary shares issuable upon exercise of the Warrants and a current prospectus relating to them is available (or the Company permits
holders to exercise their Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act).
The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination,
the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of
the ordinary shares issuable upon exercise of the Warrants. The Company will use its best efforts to cause the same to become effective
and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the
Warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the ordinary shares issuable
upon exercise of the warrants is not effective by the ninetieth (90th) day after the closing of the initial Business Combination, warrant
holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to
maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of
the Securities Act or another exemption. The Warrants will expire five years after the completion of a Business Combination or earlier
upon redemption or liquidation.
The Company may call the
Warrants for redemption, once they become exercisable :
| ● | in whole and not in part; |
| ● | at a price of $0.01 per warrant; |
| ● | upon a minimum of 30 days’ prior written notice of redemption;
and |
| ● | if, and only if, the last reported last sale price of the ordinary
shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior
to the date on which the Company sends the notice of redemption to the warrant holders. |
If the Company calls the
Warrants for redemption, management will have the option to require all holders that wish to exercise the Warrants to do so on a “cashless
basis,” as described in the warrant agreement.
The exercise price and number
of ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share capitalization,
or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of ordinary shares
at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants shares. If
the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the
Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution
from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire
worthless.
CLIMATEROCK
NOTES TO THE FINANCIAL STATEMENTS (UNAUDITED)
If: (i) the Company issues
additional ordinary shares or securities convertible into or exercisable or exchangeable for shares of ordinary shares for capital raising
purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20
per ordinary shares, with such issue price or effective issue price to be determined in good faith by the Board (and in the case of any
such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by such holder or affiliates, as applicable,
prior to such issuance) (the “New Issuance Price”); (ii) the aggregate gross proceeds from such issuances represent more than
60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the
consummation thereof (net of redemptions); and (iii) the volume weighted average trading price of the ordinary shares during the 20 trading
day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price,
the “Market Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115%
of the greater of the Market Value and the New Issuance Price and the Redemption Trigger Price ($18.00) shall be adjusted to equal to
180% of the greater of the Market Value and the Newly Issued Price.
The Company accounts for
the Public Warrants and the Private Placement Warrants as equity instruments, so long as the Company continues to meet the accounting
requirements for equity instruments.
Rights —
Each holder of a right included in the unit (the “Right”) will automatically receive one-tenth (1/10) of one share of ordinary
shares upon consummation of a Business Combination, except in cases where we are not the surviving company in a business combination,
and even if the holder of such Right redeemed all shares of ordinary shares held by it in connection with a Business Combination. No additional
consideration will be required to be paid by a holder of a Right in order to receive its additional shares upon consummation of a Business
Combination, as the consideration related thereto has been included in the unit purchase price paid for by investors in the Initial Public
Offering. If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving
entity, the definitive agreement will provide for the holders of Rights to receive the same per share consideration the holders of shares
of ordinary shares will receive in the transaction on an as-exchanged for ordinary shares basis, and each holder of a Right will be required
to affirmatively exchange its Rights in order to receive the 1/10 share underlying each Right (without paying any additional consideration)
upon consummation of a Business Combination. More specifically, the Rights holder will be required to indicate its election to exchange
the Right for the underlying shares within a fixed period of time after which period the Rights will expire worthless.
Pursuant to the Rights agreement,
a Rights holder may exchange Rights only for a whole number of shares of ordinary shares. This means that the Company will not issue fractional
shares in connection with an exchange of Rights and Rights may be exchanged only in multiples of 10 Rights (subject to adjustment for
stock splits, stock dividends, reorganizations, recapitalizations and the like). Fractional shares will either be rounded down to the
nearest whole share or otherwise addressed in accordance with the applicable provisions of the Delaware General Corporation Law.
If the Company is unable
to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders
of rights will not receive any such funds with respect to their Rights, nor will they receive any distribution from the Company’s
assets held outside of the Trust Account with respect to such Rights, and the Rights will expire worthless. Further, there are no contractual
penalties for failure to deliver securities to holders of the rights upon consummation of a Business Combination. Additionally, in no
event will the Company be required to net cash settle the Rights. Accordingly, the Rights may expire worthless.
NOTE 8. FAIR VALUE MEASUREMENTS
The following table presents
information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2022 and indicates the fair
value hierarchy of the valuation inputs the Company utilized to determine such fair value:
Description | |
Level | | |
June 30,
2022 | |
Assets: | |
| | |
| |
Marketable securities held in Trust Account | |
| 1 | | |
$ | 80,017,979 | |
Except for the foregoing,
the Company does not have any assets measured at fair value on a recurring basis at December 31, 2021.
NOTE 9. SUBSEQUENT EVENTS
The Company evaluated subsequent
events and transactions that occurred after the balance sheet date, up to August 11, 2022, the date that the financial statements were
issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References in this report
(the “Quarterly Report”) to “we,” “us” or the “Company” refer to ClimateRock. References
to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor”
refer to U.N. SDG Support LLC The following discussion and analysis of the Company’s financial condition and results of operations
should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain
information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report includes
“forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities
Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are not historical
facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All
statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this
“Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s
financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements.
Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek”
and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements
relate to future events or future performance, but reflect management’s current beliefs, based on information currently available.
A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed
in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially
from those anticipated in the forward-looking statements, please refer to our prospectus filed in connection with our Offering (as defined
below), under Cautionary Note Regarding Forward-Looking Statements and Risk Factors. The Company’s securities filings can be accessed
on the EDGAR section of the U.S. Securities and Exchange Commission’s (“SEC”) website at www.sec.gov. Except as expressly
required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements
whether as a result of new information, future events or otherwise.
Overview
The Company is a Cayman Islands
exempted company incorporated as a blank check company on December 6, 2021. The Company was formed for the purpose of a merger, share
exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses
or entities (“Business Combination”).
Although the Company is not
limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus
on opportunities in environmental protection, renewable energy, fighting climate change, and any other related industries. ClimateRock
will target companies with established operating models that have strong management teams, realigned capital structures, positive cash
flows prospects, and a clear and well-defined pathway for growing profitably over the long-term. The Company is an early stage and emerging
growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of June 30,
2022, the Company had not yet commenced any operations. All activity through June 30, 2022 relates to the Company’s
formation and the initial public offering (“Offering”), which is described below, and post-offering activities in search for a target to consummate a Business Combination. The Company will not generate any
operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
nonoperating income in the form of interest income from the proceeds derived from the Offering. The Company has selected December 31
as its fiscal year end.
Recent Developments
The registration statement
for the Company’s Offering was declared effective on April 27, 2022. On May 2, 2022,
the Company consummated its Offering of 7,875,000 units (“Units” and, with respect to the Class A ordinary shares included
in the Units being offered, the “Public Shares”) at $10.00 per Unit, including 375,000 Units that were issued pursuant to
the underwriters’ partial exercise of their over-allotment option, generating gross proceeds of $78,750,000.
The Company commenced operations
after obtaining adequate financial resources through i) the Offering of 7,875,000 Units at $10.00 per Unit (which includes 375,000 units
in connection with the underwriter’s partial exercise of the over-allotment option) and ii) the sale of 3,762,500 warrants with
an exercise price of $11.50 per warrant (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant
to the Company’s Sponsor (the “Private Placement”).
The Units were listed on
the Nasdaq Global Market (“Nasdaq”). The Company’s management has broad discretion with respect to the specific application
of the net proceeds of the Offering and sale of the Private Placement Warrants, although substantially all of the net proceeds are intended
to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one
or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (as
defined below) (net of amounts disbursed to management for working capital purposes). The Company will only complete a Business Combination
if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise
acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment
Company Act of 1940 as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully
effect a Business Combination.
Upon the closing of the Offering,
$10.15 per Unit sold in the Offering was placed in a trust account (“Trust Account”) and invested in U.S. government securities,
within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended
investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as
determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds
in the Trust Account to the Company’s shareholders, as described below.
The Sponsor, officers, directors
and advisors (the “Initial Shareholders”) have agreed (a) to vote their Founder Shares (as defined below) and any Public Shares
purchased during or after the Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s amended
and restated memorandum and articles of association with respect to the Company’s pre-Business Combination activities prior to the
consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their
Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) into the right to receive
cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender
offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to
amend the provisions of the amended and restated certificate of incorporation relating to shareholders’ rights of pre-Business Combination
activity and (d) that the Founder Shares and the Private Placement Warrants (including underlying securities) shall not participate in
any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Initial Shareholders will be
entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Offering
if the Company fails to complete its Business Combination.
Results of Operations
Our entire activity since
inception up to June 30, 2022 is related to our formation, the Offering, and we will not be generating any operating revenues until
the closing and completion of our initial Business Combination, at the earliest. We will generate nonoperating income in the form of interest
income from the proceeds derived from the Offering. Following the closing of our Offering on May 2, 2022, we expect to incur increased
expenses as a result of becoming a public company (for legal, financial reporting, accounting and auditing compliance), as well as for
due diligence expenses.
For the three months ended
June 30, 2022, the Company reported a net loss of $184,940, which consists of general and administrative expenses, offset by $86,729
of investment income earned in the Trust Account.
For the six months ended
June 30, 2022, the Company reported a net loss of $186,140, which consists of general and administrative expenses, offset by $86,729
of investment income earned in the Trust Account.
Liquidity and Capital Reserves
On May 2, 2022, we consummated
our Offering of 7,875,000 Units, including 375,000 Units that were issued pursuant to the underwriters’ partial exercise of their
over-allotment option. Simultaneously, the Company sold 3,762,500 Private Placement Warrants, including 112,500 Private Placement Warrants
that were issued pursuant to the underwriters’ partial exercise of the over-allotment option. From the proceeds of the Offering
and Private Placement Warrants, the Company retained approximately $1,100,000 for working capital needs after transfer of proceeds to
the Trust Account and payment of expenses related to the Offering and directors and officers insurance.
In order to finance transaction
costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of our officers and directors
may, but are not obligated to, loan us funds as may be required (“Working Capital Loans”). As of June 30, 2022, there
were no Working Capital Loans under this arrangement.
We do not believe we will
need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the
costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual
amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination.
Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem
a significant number of our public shares upon completion of our Business Combination, in which case we may issue additional securities
or incur debt in connection with such Business Combination.
Off-Balance Sheet Arrangements
We have no obligations, assets
or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2022.
Contractual Obligations
Registration Rights
Pursuant to a registration
rights agreement entered into on April 27, 2022, the holders of the Founder Shares (as defined below) and the Private Placement Warrants
(and their underlying securities) are entitled to registration rights. The Company will bear the expenses incurred in connection with
the filing of any registration statements pursuant to such registration rights.
Underwriting Agreement
Pursuant to the underwriting
agreement, the underwriters received a cash underwriting discount of $1,181,250 following the consummation of the Offering. The underwriters
are also entitled to a deferred commission of $2,362,500, which will be payable solely in the event that the Company completes a Business
Combination. In addition, the underwriters also received 118,125 Units in the Offering, with such Units restricted from sale until the
closing of the Business Combination and with no redemption rights from the Trust Account.
Additionally, the Company
granted the underwriters for a period beginning on the closing of the Offering and ending on the earlier of the 12 month anniversary of
the closing of a Business Combination or April 27, 2025, a right of first refusal to act as (i) exclusive financial advisor in connection
with all of the Company’s proposed business combinations for a fee of up to 6.0% of the proceeds of the Offering (subject to the
Company’s right to allocate up to 50% of such fee to another financial institution or extinguish such amount in Company’s
sole discretion), and (ii) sole investment banker, sole book-runner and/or sole placement agent, at underwriters’ sole discretion,
for each and every future public and private equity and debt offering, including all equity linked financings, during such period for
the Company or any successor to it or any of its subsidiaries, on terms agreed to by both the Company and underwriters in good faith.
Related Party Transactions
Founder Shares
During the period ended December
31, 2021, we issued an aggregate of 2,156,250 Class B ordinary shares (the “Founder Shares”) to the Sponsor for an aggregate
purchase price of $25,000 in cash. The Founder Shares included an aggregate of up to 281,250 shares subject to forfeiture by the Sponsor
to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Initial Shareholders will collectively
own 20% of our issued and outstanding shares after the Offering (assuming the Initial Shareholders do not purchase any Public Shares in
the Offering and excluding the securities underlying the Private Placement Warrants).
On May 2, 2022, the underwriters
partially exercised the over-allotment option in respect of 375,000 Units and, as agreed with the Company, the underwriters waived their
right to further exercise the option on May 5, 2022. Accordingly, a total of 93,750 of the Founder Shares are no longer subject to forfeiture
on May 2, 2022, and 187,500 of the Founder Shares were forfeited, resulting in an aggregate of 1,968,750 Founder Shares issued and outstanding.
The Initial Shareholders
have agreed not to transfer, assign or sell any of the Founder Shares (except to certain permitted transferees) until the earlier of (i)
six months after the date of the consummation of the Company’s initial Business Combination or (ii) the date on which we consummate
a liquidation, merger, share exchange or other similar transaction which results in all of our shareholders having the right to exchange
their ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other
agreements of our initial shareholders with respect to any Founder Shares.
Promissory Note
The member of the Sponsor
has agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Offering (the “Note”). The
Note is non-interest bearing, unsecured and was due on the earlier of September 30, 2022 or the closing of the Offering. The Company intends
to repay the Note from the Company’s working capital account. As of June 30, 2022, the Company has not borrowed any funds under
the Note. The Note expired on May 2, 2022 and will not be extended or renewed.
Loan with Related Party
The Company has agreed to
borrow up to $500,000 from Eternal B.V., an affiliate of the Company through common ownership, to be used for the payment of costs related
to the Initial Public Offering (the “Loan”). Pursuant to the loan agreement and its subsequent amendments, the Loan is non-interest
bearing, unsecured and was due on the earlier of March 31, 2024 or the closing of the Offering. The Loan was fully repaid to the affiliate
in June 2022 (see Note 5).
Administrative service fee
The Company entered
into an administrative services agreement (the “Administrative Services Agreement”) with the Sponsor on April 27, 2022
whereby the Sponsor will perform certain services for the Company for a monthly fee of $10,000. On May 2, 2022, the Sponsor entered
into an assignment agreement with Gluon Group, an affiliate of the Company, to provide the services detailed in the Administrative
Service Agreement. An officer of the Company owns 50% shares of Gluon Group and serves as managing partner. As of June 30, 2022,
$10,000 has been paid to Gluon Group for such services and $10,000 has been accrued, an additional $5,000 was also paid to Gluon
Group as a reimbursement of travel expense.
Critical Accounting Policies
The preparation of financial
statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities
at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from
those estimates. We had identified the following as its critical accounting policies:
Deferred offering costs
The Company complies with
the requirements of the Financial Accounting Standard Board (the “FASB”) Accounting Standards Codification (“ASC”)
340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offerings.” Offering costs, consist of legal,
accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public
Offering, were charged to shareholders’ equity upon the completion of the Initial Public Offering. As of December 31, 2021, deferred
offering costs amounted to $83,343 and consisted of legal, accounting, and underwriting fees. Upon consummation of the IPO on May 2, 2022,
total offering costs related to the IPO were $5,093,930, and was allocated between the Public Shares, public warrants and public rights
based on their relative fair values at the date of issuance. Accordingly, $4,647,702 was allocated to the Public Shares and charged to
temporary equity (see Note 3).
Net loss per share
The Company complies with
accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” In order to determine the net income (loss)
attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable
to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less
interest income in trust account less any dividends paid. We then allocated the undistributed income (loss) ratably based on the weighted
average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption
value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders. At June 30,
2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary
shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the
periods presented.
Ordinary shares subject to possible redemption
The Company accounts for
its Class A ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing
Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and
are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are
either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s
control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s
public shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence
of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value (plus any
interest earned and/or dividends on the Trust Account) as temporary equity, outside of the shareholders’ equity section of the Company’s
balance sheets.
Recent accounting pronouncements
Management does not believe
that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have an effect on the Company’s
financial statements.
Risks and uncertainties
Management is currently evaluating
the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect
on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily
determinable as of the date of these financial statements.
Factors that may adversely affect our results
of operations
Our results of operations
and our ability to complete a Business Combination may be adversely affected by various factors that could cause economic uncertainty
and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things,
downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply
chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and
the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. We cannot at this time fully
predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact
our business and our ability to complete a Business Combination.